Multimodal Machine Learning for Parkinson's Disease Prediction: Fusion Analysis of Speech and Tremor Features

This project constructs a multimodal machine learning framework that integrates speech biomarkers and hand tremor features, using ensemble learning and deep learning models to achieve early prediction of Parkinson's disease. It aims to address the problems of strong subjectivity in traditional diagnosis and unobvious early symptoms, and has important clinical and social value.

Parkinson's disease is a common neurodegenerative disease with over 10 million patients worldwide, and its prevalence is increasing with aging. Early diagnosis is crucial for delaying disease progression and improving quality of life, but traditional diagnosis relying on clinical assessment faces challenges such as strong subjectivity. This project, developed by Sravani Ladi, uses multimodal machine learning methods to build an automated prediction system.

Speech Features: Parkinson's disease (PD) affects vocal muscles, leading to quantifiable changes such as voice tremors, reduced volume, and monotone intonation; Tremor Features: 70% of patients have tremor as the first symptom, which can be captured by sensors for frequency (4-6Hz), amplitude, etc.; Fusion Advantages: Using either alone has limitations (speech is affected by environment, tremor is not obvious in all patients), and fusion can improve robustness and accuracy.

Data Preprocessing: Speech (noise reduction, frame segmentation, extraction of time-domain/frequency-domain/pathological features); Tremor (filtering, time-domain/frequency-domain/time-frequency analysis); Feature Engineering: Statistical screening, RFE optimization, standardization/PCA dimensionality reduction; Models: Ensemble learning (Random Forest, Gradient Boosting, SVM); Deep learning (MLP, CNN, RNN/LSTM); Fusion Strategies: Early/late/mid-level fusion; Evaluation: K-fold cross-validation, multiple metrics (accuracy, F1 score, AUC-ROC), SHAP interpretability analysis.

Early Screening: Community screening, physical examination assistance, remote monitoring; Disease Monitoring: Drug effect evaluation, progression tracking, personalized treatment; Research Support: Large-scale data analysis, subtype identification, efficacy prediction.

Multimodal Fusion: Organically combines speech and tremor to provide comprehensive pathological information; Non-invasive: Non-invasive collection, low cost, easy operation; Automation: Highly automated process, reduces human interference, easy to promote.

Data Limitations: Limited sample size, data quality affected by environment/equipment, annotation accuracy; Generalization Ability: Population differences, disease stage differences, comorbidity interference; Technical Challenges: Real-time processing, privacy protection, model updates.

Future Directions: Expand modalities such as gait/handwriting, explore Transformer architecture, federated learning, mobile app development, large-scale clinical validation; Summary: This project demonstrates an innovative application of medical AI, provides a new path for neurodegenerative disease screening, and is an example of interdisciplinary cooperation.